Android app on Google Play

Mylan (MYL) Receives FDA Approval for Generic Version of Takeda's Actoplus Met

June 27, 2012 1:30 PM EDT Send to a Friend
Bloomberg reporting Mylan (NYSE: MYL) has won FDA approval for its generic version of Takeda's actoplus met.




You May Also Be Interested In


Related Categories

FDA, Rumors

Add Your Comment